News 29 fév 2024 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...
Actualités 03 nov 2023 L’EPFL et Novochizol collaborent à la conception d’immunothérapies plus efficaces Une collaboration entre le Laboratoire de Biomatériaux pour l’Immuno-ingénierie de l’EPFL et Novochizol vise à révolutionner le traitement du can...
News 16 oct 2023 Adiposs completes the phase I clinical trial of its flagship product ImageBAT Geneva-based biotech Adiposs casts a ray of hope onto the horizons of cancer treatment and patient care with the successful conclusion of the Pha...
Aktuell 20 déc 2023 Proteomedix und Blue Water Biotech gründen Onconetix Proteomedix ist von Blue Water Biotech in Cincinnati übernommen worden. Beide haben gemeinsam das Unternehmen Onconetix Inc. gegründet. Die neue ...
Actualités 17 mai 2023 Les start-ups genevoises Fluosphera, Kylys Aesthetics et Consulto reçoivent le soutien du FIF La Fondation Genevoise pour l’Innovation Technologique (Fongit) a annoncé les derniers bénéficiaires du Fongit Innovation Fund (FIF). Fluosphera ...
News 05 mar 2024 Immunocore turns to Oncobit platform The British biotechnology company Immunocore will in future make use of the platform developed by Oncobit, a medtech firm and spin-off from the U...
Actualités 17 oct 2023 Voltiris, Limula et Parithera bénéficient du Start-Up Fund du Biopôle Les start-up vaudoises Voltiris, Limula et Parithera accélèrent le développement de leurs projets innovants grâce à un soutien et un financement ...
News 20 déc 2023 Proteomedix and Blue Water Biotech jointly found Onconetix Proteomedix has been acquired by Blue Water Biotech, which is based in Cincinnati in the US State of Ohio. The two firms have now jointly founded...
News 07 juil 2023 Roche and ETH training the next generation of researchers Roche, the Basel-based life sciences firm, and the Swiss Federal Institute of Technology in Zurich (ETH) are joining forces to train biomedical r...
News 30 jan 2024 Top Stories from Western Switzerland (January 2024) From groundbreaking advancements in agrifood and robotics to strategic economic reforms and pioneering research in space and medicine, discover W...
News 14 fév 2024 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
Analyse 22 mar 2021 Digitales B2B-Marketing in China Die digitale Landschaft in China ist einzigartig und in rasanter Entwicklung, ganz anders als in Europa. Um herauszufinden, wo Schweizer Unterneh...
News 22 mar 2023 FIF funding awarded to three innovative Geneva-based projects Geneva-based start-ups Plair, Endotelix, and Dr. Beat Walpoth have received the Fongit Innovation Fund (FIF) for their remarkable innovations.
News 10 jan 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
Actualités 30 jan 2024 Les Grands Titres de Suisse occidentale (Janvier 2024) Des avancées révolutionnaires dans l’agroalimentaire et la robotique aux réformes économiques stratégiques en passant par la recherche pionnière ...
News 09 jan 2024 Molecular Partners and Orano Med announce strategic partnership Molecular Partners and Orano Med are joining forces for the development of protein drugs known as DARPin therapeutics. The radioactive payloads o...
News 22 jan 2024 DISCO Pharmaceuticals secures seed funding of 20 million euros DISCO Pharmaceuticals has secured seed funding of 20 million euros and officially launched the business. The team was the first to develop a meth...
Événements S-GE Facteurs de succès clés pour faire des affaires au Japon 23 avr 2024 10:15–12:10 Zürich Suisse